Abstract
Summary
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
The global Varicella Vaccine market is projected to reach US$ 7104.7 million by 2032 from an estimated US$ 4527.3 million in 2026, at a CAGR of 7.8% during 2026 and 2032.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Kids Injection
Adults Injection
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Varicella Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Varicella Vaccine market is projected to reach US$ 7104.7 million by 2032 from an estimated US$ 4527.3 million in 2026, at a CAGR of 7.8% during 2026 and 2032.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Kids Injection
Adults Injection
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Varicella Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Varicella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Varicella Vaccine Market Size Growth Rate by Type (2021 VS 2025 VS 2032)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market by Application
1.3.1 Global Varicella Vaccine Market Size Growth Rate by Application (2021 VS 2025 VS 2032)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2021-2032
2.1.2 Global Varicella Vaccine Sales 2021-2032
2.2 Varicella Vaccine Market Size by Region: 2025 Versus 2032
2.3 Varicella Vaccine Sales by Region (2021-2032)
2.3.1 Global Varicella Vaccine Sales by Region: 2021-2026
2.3.2 Global Varicella Vaccine Sales Forecast by Region (2027-2032)
2.3.3 Global Varicella Vaccine Sales Market Share by Region (2021-2032)
2.4 Varicella Vaccine Market Estimates and Projections by Region (2027-2032)
2.4.1 Global Varicella Vaccine Revenue by Region: 2021-2026
2.4.2 Global Varicella Vaccine Revenue Forecast by Region (2027-2032)
2.4.3 Global Varicella Vaccine Revenue Market Share by Region (2021-2032)
3 Global Varicella Vaccine by Manufacturers
3.1 Global Top Varicella Vaccine Manufacturers by Sales
3.1.1 Global Varicella Vaccine Sales by Manufacturer (2021-2026)
3.1.2 Global Varicella Vaccine Sales Market Share by Manufacturer (2021-2026)
3.2 Global Top Varicella Vaccine Manufacturers by Revenue
3.2.1 Global Varicella Vaccine Revenue by Manufacturer (2021-2026)
3.2.2 Global Varicella Vaccine Revenue Share by Manufacturer (2021-2026)
3.3 Global Varicella Vaccine Price by Manufacturer (2021-2026)
3.4 Competitive Landscape
3.4.1 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) & (2021-2026)
3.4.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Varicella Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Varicella Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Varicella Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck Varicella Vaccine Products Offered
4.1.4 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.1.5 Merck Varicella Vaccine Sales by Product in 2025
4.1.6 Merck Varicella Vaccine Sales by Application in 2025
4.1.7 Merck Varicella Vaccine Sales by Geographic Area in 2025
4.1.8 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Varicella Vaccine Products Offered
4.2.4 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.2.5 GSK Varicella Vaccine Sales by Product in 2025
4.2.6 GSK Varicella Vaccine Sales by Application in 2025
4.2.7 GSK Varicella Vaccine Sales by Geographic Area in 2025
4.2.8 GSK Recent Developments
4.3 Shanghai Institute
4.3.1 Shanghai Institute Company Information
4.3.2 Shanghai Institute Description, Business Overview
4.3.3 Shanghai Institute Varicella Vaccine Products Offered
4.3.4 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.3.5 Shanghai Institute Varicella Vaccine Sales by Product in 2025
4.3.6 Shanghai Institute Varicella Vaccine Sales by Application in 2025
4.3.7 Shanghai Institute Varicella Vaccine Sales by Geographic Area in 2025
4.3.8 Shanghai Institute Recent Developments
4.4 BCHT
4.4.1 BCHT Company Information
4.4.2 BCHT Description, Business Overview
4.4.3 BCHT Varicella Vaccine Products Offered
4.4.4 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.4.5 BCHT Varicella Vaccine Sales by Product in 2025
4.4.6 BCHT Varicella Vaccine Sales by Application in 2025
4.4.7 BCHT Varicella Vaccine Sales by Geographic Area in 2025
4.4.8 BCHT Recent Developments
4.5 Changsheng
4.5.1 Changsheng Company Information
4.5.2 Changsheng Description, Business Overview
4.5.3 Changsheng Varicella Vaccine Products Offered
4.5.4 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.5.5 Changsheng Varicella Vaccine Sales by Product in 2025
4.5.6 Changsheng Varicella Vaccine Sales by Application in 2025
4.5.7 Changsheng Varicella Vaccine Sales by Geographic Area in 2025
4.5.8 Changsheng Recent Developments
4.6 Keygen
4.6.1 Keygen Company Information
4.6.2 Keygen Description, Business Overview
4.6.3 Keygen Varicella Vaccine Products Offered
4.6.4 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.6.5 Keygen Varicella Vaccine Sales by Product in 2025
4.6.6 Keygen Varicella Vaccine Sales by Application in 2025
4.6.7 Keygen Varicella Vaccine Sales by Geographic Area in 2025
4.6.8 Keygen Recent Development
4.7 Green Cross
4.7.1 Green Cross Company Information
4.7.2 Green Cross Description, Business Overview
4.7.3 Green Cross Varicella Vaccine Products Offered
4.7.4 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.7.5 Green Cross Varicella Vaccine Sales by Product in 2025
4.7.6 Green Cross Varicella Vaccine Sales by Application in 2025
4.7.7 Green Cross Varicella Vaccine Sales by Geographic Area in 2025
4.7.8 Green Cross Recent Development
4.8 Biken
4.8.1 Biken Company Information
4.8.2 Biken Description, Business Overview
4.8.3 Biken Varicella Vaccine Products Offered
4.8.4 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.8.5 Biken Varicella Vaccine Sales by Product in 2025
4.8.6 Biken Varicella Vaccine Sales by Application in 2025
4.8.7 Biken Varicella Vaccine Sales by Geographic Area in 2025
4.8.8 Biken Recent Development
5 Breakdown Data by Type
5.1 Global Varicella Vaccine Sales by Type (2021-2032)
5.1.1 Global Varicella Vaccine Sales by Type (2021-2026)
5.1.2 Global Varicella Vaccine Sales Forecast by Type (2027-2032)
5.1.3 Global Varicella Vaccine Sales Market Share by Type (2021-2032)
5.2 Global Varicella Vaccine Revenue Forecast by Type (2021-2032)
5.2.1 Global Varicella Vaccine Revenue by Type (2021-2026)
5.2.2 Global Varicella Vaccine Revenue Forecast by Type (2027-2032)
5.2.3 Global Varicella Vaccine Revenue Market Share by Type (2021-2032)
5.3 Varicella Vaccine Average Selling Price (ASP) by Type (2021-2032)
6 Breakdown Data by Application
6.1 Global Varicella Vaccine Sales by Application (2021-2032)
6.1.1 Global Varicella Vaccine Sales by Application (2021-2026)
6.1.2 Global Varicella Vaccine Sales Forecast by Application (2027-2032)
6.1.3 Global Varicella Vaccine Sales Market Share by Application (2021-2032)
6.2 Global Varicella Vaccine Revenue Forecast by Application (2021-2032)
6.2.1 Global Varicella Vaccine Revenue by Application (2021-2026)
6.2.2 Global Varicella Vaccine Revenue Forecast by Application (2027-2032)
6.2.3 Global Varicella Vaccine Revenue Market Share by Application (2021-2032)
6.3 Varicella Vaccine Average Selling Price (ASP) by Application (2021-2032)
7 North America
7.1 North America Varicella Vaccine Market Size YoY Growth 2021-2032
7.2 North America Varicella Vaccine Market Facts & Figures by Country
7.2.1 North America Varicella Vaccine Sales by Country (2021-2032)
7.2.2 North America Varicella Vaccine Revenue by Country (2021-2032)
7.3 North America Varicella Vaccine Sales by Type (2021-2026)
7.4 North America Varicella Vaccine Sales by Application (2021-2026)
8 Asia-Pacific
8.1 Asia-Pacific Varicella Vaccine Market Size YoY Growth 2021-2032
8.2 Asia-Pacific Varicella Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Varicella Vaccine Sales by Region (2021-2032)
8.2.2 Asia-Pacific Varicella Vaccine Revenue by Region (2021-2032)
8.3 Asia-Pacific Varicella Vaccine Sales by Type (2021-2026)
8.4 Asia-Pacific Varicella Vaccine Sales by Application (2021-2026)
9 Europe
9.1 Europe Varicella Vaccine Market Size YoY Growth 2021-2032
9.2 Europe Varicella Vaccine Market Facts & Figures by Country
9.2.1 Europe Varicella Vaccine Sales by Country (2021-2032)
9.2.2 Europe Varicella Vaccine Revenue by Country (2021-2032)
9.3 Europe Varicella Vaccine Sales by Type (2021-2026)
9.4 Europe Varicella Vaccine Sales by Application (2021-2026)
10 Latin America
10.1 Latin America Varicella Vaccine Market Size YoY Growth 2021-2032
10.2 Latin America Varicella Vaccine Market Facts & Figures by Country
10.2.1 Latin America Varicella Vaccine Sales by Country (2021-2032)
10.2.2 Latin America Varicella Vaccine Revenue by Country (2021-2032)
10.3 Latin America Varicella Vaccine Sales by Type (2021-2026)
10.4 Latin America Varicella Vaccine Sales by Application (2021-2026)
11 Middle East and Africa
11.1 Middle East and Africa Varicella Vaccine Market Size YoY Growth 2021-2032
11.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Varicella Vaccine Sales by Country (2021-2032)
11.2.2 Middle East and Africa Varicella Vaccine Revenue by Country (2021-2032)
11.3 Middle East and Africa Varicella Vaccine Sales by Type (2021-2026)
11.4 Middle East and Africa Varicella Vaccine Sales by Application (2021-2026)
12 Supply Chain and Sales Channel Analysis
12.1 Varicella Vaccine Supply Chain Analysis
12.2 Varicella Vaccine Key Raw Materials and Upstream Suppliers
12.3 Varicella Vaccine Clients Analysis
12.4 Varicella Vaccine Sales Channel and Sales Model Analysis
12.4.1 Varicella Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Varicella Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Varicella Vaccine Distributors
13 Market Dynamics
13.1 Varicella Vaccine Industry Trends
13.2 Varicella Vaccine Market Drivers
13.3 Varicella Vaccine Market Challenges
13.4 Varicella Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer